US stock exchanges are holding back before the Fed meeting: No clear impetus from the reporting season

US stock exchanges are holding back before the Fed meeting: No clear impetus from the reporting season

According to a report by www.wallstreet-online.de The US stock markets took a more leisurely pace on Tuesday after recovering significantly at the start of the week. The markets are holding back ahead of the US Federal Reserve's upcoming interest rate decision. In addition, there is no clear impetus from the current reporting season, which features a wave of new company figures of varying quality.

The Dow Jones Industrial is down 0.13 percent in early trading, the S&P 500 is down 0.03 percent and the Nasdaq 100 is down 0.20 percent.

The markets are looking forward to tomorrow's Fed meeting. Interest rates are expected to remain unchanged, but it remains questionable how restrictively this decision will be communicated.

The reporting season had its share of light and shadow. Caterpillar was on the downside as shares of the construction equipment maker slipped 6.1 percent. Experts see this as a sign of declining demand. Two large pharmaceutical companies also suffered losses after presenting their quarterly figures. Amgen shares lost 3.7 percent and Pfizer shares lost 0.7 percent. At Amgen, the different sales development of individual drugs was criticized, while Pfizer's sales development was below analysts' expectations.

At GE Healthcare, on the other hand, an increase of 6.7 percent was recorded as the medical technology manufacturer was more profitable than expected. There were also noticeable price changes in the small cap sector. Jetblue shares slipped nearly 18 percent, while Pinterest shares rose 19 percent. Semiconductor developer Wolfspeed recorded an increase of 22 percent.